Comparative effectiveness of antipsychotic drugs in schizophrenia

Por Stroup, T. Scott, A. Lieberman, Jeffrey, S. Swartz, Marvin, McEvoy, Joseph P.
Publicado em 2000

Religious Coping and Quality of LifefAmong Individuals Living With Schizophrenia

Por Nolan, Jennifer A., McEvoy, Joseph P., Koenig, Harold G., Hooten, Elizabeth G., Whetten, Kathryn, Pieper, Carl F.
Publicado em 2012

Effectiveness of lurasidone in schizophrenia or schizoaffective patients switched from other antipsychotics: a 6-month, open-label, extension study

Por Citrome, Leslie, Weiden, Peter J, McEvoy, Joseph P, Correll, Christoph U., Cucchiaro, Josephine, Hsu, Jay, Loebel, Antony
Publicado em 2013

Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis

Por Need, Anna C, Keefe, Richard SE, Ge, Dongliang, Grossman, Iris, Dickson, Sam, McEvoy, Joseph P, Goldstein, David B
Publicado em 2009

Effectiveness of Switching from Antipsychotic Polypharmacy to Monotherapy

Por Essock, Susan M., Schooler, Nina R., Stroup, T. Scott, McEvoy, Joseph P., Rojas, Ingrid, Jackson, Carlos, Covell, Nancy H
Publicado em 2011

Effectiveness of Switching from Long-Acting Injectable Fluphenazine or Haloperidol Decanoate to Long-Acting Injectable Risperidone Microspheres

Por Covell, Nancy H, McEvoy, Joseph P., Schooler, Nina R., Stroup, T. Scott, Jackson, Carlos, Rojas, Ingrid, Essock, Susan M.
Publicado em 2012

The Impact of Obesity on Health Care Costs among Persons with Schizophrenia

Por Chwastiak, Lydia A., Rosenheck, Robert A., McEvoy, Joseph P., Stroup, T. Scott, Swartz, Marvin S., Davis, Sonia M., Lieberman, Jeffrey A.
Publicado em 2008

Prevalence of Celiac Disease and Gluten Sensitivity in the United States Clinical Antipsychotic Trials of Intervention Effectiveness Study Population

Por Cascella, Nicola G., Kryszak, Debra, Bhatti, Bushra, Gregory, Patricia, Kelly, Deanna L., Mc Evoy, Joseph P., Fasano, Alessio, Eaton, William W.
Publicado em 2011

What CATIE Found: Results From the Schizophrenia Trial

Por Swartz, Marvin S., Stroup, T. Scott, McEvoy, Joseph P., Davis, Sonia M., Rosenheck, Robert A., Keefe, Richard S. E., Hsiao, John K., Lieberman, Jeffrey A.
Publicado no Psychiatr Serv (2008)

Impact of Second-Generation Antipsychotics and Perphenazine on Depressive Symptoms in a Randomized Trial of Treatment for Chronic Schizophrenia

Por Addington, Donald E., Mohamed, Somaia, Rosenheck, Robert A., Davis, Sonia M., Stroup, Thomas Scott, McEvoy, Joseph P., Swartz, Marvin S., Lieberman, Jeffrey A.
Publicado no J Clin Psychiatry (2010)

The RAISE Connection Program: Psychopharmacological Treatment of People with a First Episode of Schizophrenia

Por Kreyenbuhl, Julie, Medoff, Deborah, McEvoy, Joseph P., Smith, Thomas E., Hackman, Ann, Nossel, Ilana R., Dixon, Lisa B., Essock, Susan M., Buchanan, Robert W.
Publicado no Psychiatr Serv (2016)

Results of Phase 3 of the CATIE Schizophrenia Trial

Por Stroup, T. Scott, Lieberman, Jeffrey A., McEvoy, Joseph P., Davis, Sonia M., Swartz, Marvin S., Keefe, Richard S.E., Miller, Alexander L., Rosenheck, Robert A., Hsiao, John K.
Publicado em 2008

Longitudinal consent-related abilities among research participants with schizophrenia: Results from the CATIE study

Por Stroup, T. Scott, Appelbaum, Paul S., Gu, Hongbin, Hays, Spencer, Swartz, Marvin S., Keefe, Richard S.E., Kim, Scott, Manschreck, Theo, Boshes, Roger, McEvoy, Joseph P., Lieberman, Jeffrey A.
Publicado em 2011

Cost-Effectiveness of Long-Acting Injectable Paliperidone Palmitate vs. Haloperidol Decanoate in Maintenance Treatment of Schizophrenia

Por Rosenheck, Robert A., Leslie, Douglas L., Sint, Kyaw J., Lin, Haiqun, Li, Yue, McEvoy, Joseph P., Byerly, Matthew J., Hamer, Robert M., Swartz, Marvin S., Stroup, T. Scott
Publicado no Psychiatr Serv (2016)

Comparison of antipsychotic medication effects on reducing violence in people with schizophrenia

Por Swanson, Jeffrey W., Swartz, Marvin S., Van Dorn, Richard A., Volavka, Jan, Monahan, John, Stroup, T. Scott, McEvoy, Joseph P., Wagner, H. Ryan, Elbogen, Eric B., Lieberman, Jeffrey A.
Publicado em 2008

Effects of switching from olanzapine, quetiapine, and risperidone to aripiprazole on 10-year coronary heart disease risk and metabolic syndrome status: Results from a randomized co...

Por Stroup, T. Scott, Byerly, Matthew J., Nasrallah, Henry A., Ray, Neepa, Khan, Ahsan Y., Lamberti, J. Steven, Glick, Ira D., Steinbook, Richard M., McEvoy, Joseph P., Hamer, Robert M.
Publicado em 2013

Genetic Determinants of Variable Metabolism Have Little Impact on the Clinical Use of Leading Antipsychotics in the CATIE study

Por Grossman, Iris, Sullivan, Patrick F., Walley, Nicole, Liu, Youfang, Dawson, Jeffrey R., Gumbs, Curtis, Gaedigk, Andrea, Leeder, J. Steven, McEvoy, Joseph P., Weale, Michael E., Goldstein, David B.
Publicado em 2008

Inflammatory Markers in Schizophrenia: Comparing Antipsychotic Effects in Phase 1 of the CATIE Schizophrenia Trial

Por Meyer, Jonathan M., McEvoy, Joseph P., Davis, Vicki G., Goff, Donald C., Nasrallah, Henry A., Davis, Sonia M., Hsiao, John K., Swartz, Marvin S., Stroup, T. Scott, Lieberman, Jeffrey A.
Publicado em 2009

Effectiveness of Paliperidone Palmitate vs. Haloperidol Decanoate for Maintenance Treatment of Schizophrenia: A Randomized Clinical Trial

Por McEvoy, Joseph P., Byerly, Matthew, Hamer, Robert M., Dominik, Rosalie, Swartz, Marvin S., Rosenheck, Robert A., Ray, Neepa, Lamberti, J. Steven, Buckley, Peter F., Wilkins, Tania M., Stroup, T. Scott
Publicado em 2014

Comparison of Antipsychotics for Metabolic Problems (CAMP): A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole...

Por Stroup, T. Scott, McEvoy, Joseph P., Ring, Kimberly D., Hamer, Robert H., LaVange, Lisa M., Swartz, Marvin S., Rosenheck, Robert A., Perkins, Diana O., Nussbaum, Abraham M., Lieberman, Jeffrey A.
Publicado em 2011